These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 15505109

  • 21. Drug treatment for chronic systolic heart failure.
    Mörike K, Sindermann JR.
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S170-2. PubMed ID: 20101534
    [Abstract] [Full Text] [Related]

  • 22. Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system.
    De Mello WC.
    J Mol Cell Cardiol; 2004 Aug; 37(2):431-8. PubMed ID: 15276013
    [Abstract] [Full Text] [Related]

  • 23. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP.
    Cardiol Rev; 2006 Aug; 14(2):81-7. PubMed ID: 16493245
    [Abstract] [Full Text] [Related]

  • 24. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K, Ferro A.
    Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
    [Abstract] [Full Text] [Related]

  • 25. [The defibrillator is not a comprehensive healing method].
    Stiefelhagen P.
    MMW Fortschr Med; 2006 Aug 03; 148(31-32):14. PubMed ID: 16938917
    [No Abstract] [Full Text] [Related]

  • 26. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS.
    Am J Med; 2007 Dec 03; 120(12):1090.e1-8. PubMed ID: 18060931
    [Abstract] [Full Text] [Related]

  • 27. Mineralocorticoid receptor blockade in chronic heart failure.
    Struthers AD.
    J Hum Hypertens; 1995 Jun 03; 9(6):443-6. PubMed ID: 7473525
    [Abstract] [Full Text] [Related]

  • 28. Pharmacologic advances in long-term heart failure management.
    Pfeffer MA.
    Am Heart Hosp J; 2004 Jun 03; 2(4 Suppl 1):15-20. PubMed ID: 15539971
    [Abstract] [Full Text] [Related]

  • 29. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA.
    J Hypertens; 2006 Jun 03; 24(6):983-91. PubMed ID: 16685192
    [Abstract] [Full Text] [Related]

  • 30. [The renin-angiotensin system].
    Hilgers KF.
    Urologe A; 2009 Aug 03; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?
    Hoppe UC.
    Clin Res Cardiol; 2007 Apr 03; 96(4):196-8. PubMed ID: 17294351
    [No Abstract] [Full Text] [Related]

  • 32. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
    Shah NC, Pringle S, Struthers A.
    J Renin Angiotensin Aldosterone Syst; 2006 Mar 03; 7(1):20-30. PubMed ID: 17083070
    [Abstract] [Full Text] [Related]

  • 33. The CHARM program: study design leads to findings of clinical and public health importance.
    Hennekens CH, Pfeffer MA, Swedberg K.
    J Cardiovasc Pharmacol Ther; 2007 Jun 03; 12(2):124-6. PubMed ID: 17562782
    [Abstract] [Full Text] [Related]

  • 34. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR.
    An R Acad Nac Med (Madr); 2006 Jun 03; 123(3):617-30. PubMed ID: 17451101
    [Abstract] [Full Text] [Related]

  • 35. Heart failure management. Interview with Karl Swedberg.
    Swedberg K.
    Timely Top Med Cardiovasc Dis; 2007 Jan 09; 11():E1. PubMed ID: 17369884
    [No Abstract] [Full Text] [Related]

  • 36. Guidelines for choosing drugs in chronic heart failure.
    Tabrizchi R.
    Vasc Health Risk Manag; 2005 Jan 09; 1(3):171-2. PubMed ID: 17319102
    [No Abstract] [Full Text] [Related]

  • 37. [Management of advanced chronic heart failure].
    Oliva F, Macera F, Verde A, Frigerio M.
    G Ital Cardiol (Rome); 2008 Oct 09; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
    [Abstract] [Full Text] [Related]

  • 38. Protocol Underemphasizes beta-blockers.
    Chase SL.
    J Am Pharm Assoc (Wash); 2001 Oct 09; 41(6):793-4. PubMed ID: 11765101
    [No Abstract] [Full Text] [Related]

  • 39. Drugs for left ventricular remodeling in heart failure.
    Frigerio M, Roubina E.
    Am J Cardiol; 2005 Dec 19; 96(12A):10L-18L. PubMed ID: 16399088
    [Abstract] [Full Text] [Related]

  • 40. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G, Sabbadini G, Zecchin M, Di Lenarda A.
    G Ital Cardiol (Rome); 2007 Sep 19; 8(9):559-67. PubMed ID: 17972425
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.